A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension
Clinical trial NCT03533114 · COMPLETED
Trial details
- NCT number
- NCT03533114
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2020-06-12
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.